NicholasFidelmanMD
Radiology • San Francisco, CAInterventional Neuroradiology, Vascular & Interventional Radiology
Assistant Professor, Radiology, UCSF School of Medicine
Dr. Fidelman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
505 Parnassus Avenue, Box 0628
Ucsf Department Of Radiology
San Francisco, CA 94143Phone+1 415-353-1000Fax+1 415-476-0616- Is this information wrong?
Education & Training
University of California (San Francisco)Residency, Radiology-Diagnostic, 2003 - 2007
St Mary's Hospital and Medical CenterInternship, Internal Medicine, 2002 - 2003- University of California San Francisco School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2003 - 2025- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Clinical Trials
- Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma Start of enrollment: 2010 May 01
- Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases Start of enrollment: 2010 May 01
- Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer Start of enrollment: 2012 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Intra-arterial Peptide Receptor Radionuclide Therapy for the Treatment of Hepatic Neuroendocrine Tumor Metastases: Hope or Hype?Michael V Khanjyan, Nicholas Fidelman> ;Seminars in Interventional Radiology. 2024 Feb 1
- Liver-Directed Therapy for Neuroendocrine Tumor Metastases in the Era of Peptide Receptor Radionuclide Therapy.Rabei, R., Fidelman, N.> ;Current Treatment Options in Oncology. 2023 Dec 1
- 1 citationsPer-patient Negative Predictive Value of the CT and MRI Liver Imaging Reporting and Data System Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma.Hassan, O., Behr, S., Ohliger, M., Fowler, K., Gill, R., Fidelman, N., Mehta, N., Choi, H.> ;Radiology. 2023 Dec 1
- Join now to see all
Lectures
- Phase I prospective trial of TAS-102 (trifluride and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases.ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
- WOMEN’S IMAGING IN WINE COUNTRY NAPA, CALIFORNIAUCSF - Helen Diller Family Comprehensive Cancer Center, Napa, California - 9/29/2013
- WOMEN’S IMAGING IN WINE COUNTRY NAPA, CALIFORNIAUCSF - Helen Diller Family Comprehensive Cancer Center, Napa, California - 9/29/2013
Press Mentions
Breaking the Boundaries Between Radiology and Oncology: GU Oncology Profiles Thomas a. Hope, MDApril 28th, 2022- K. Pallav Kolli, MD, Appointed Chief of Interventional RadiologyOctober 18th, 2021
- Recognizing the Role of Nurses in the Growth of Radiology Services at UCSFMay 7th, 2021
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
UCSF Medical CenterSan Francisco, California
Zuckerberg San Francisco General Hospital and Trauma CenterSan Francisco, California
San Francisco VA Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
